BRPI0922566A2 - polimorfo cristalino, composição farmacêutica, composto, e, métodos para preparar um composto, e para tratar uma doença. - Google Patents

polimorfo cristalino, composição farmacêutica, composto, e, métodos para preparar um composto, e para tratar uma doença.

Info

Publication number: BRPI0922566A2
Authority: BR; Brazil
Prior art keywords: compound; disease; treating; preparing; methods
Prior art date: 2008-12-17

Application number

BRPI0922566A

Other languages

English (en)

Inventor

A Norton Beth

Wheeler Conrad

Todd Dan

Chen Pingyun

Original Assignee

Anacor Pharmaceuticals Inc

Glaxosmithkline Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-12-17

Filing date

2009-12-17

Publication date

2017-03-28

2009-12-17 Application filed by Anacor Pharmaceuticals Inc, Glaxosmithkline Llc filed Critical Anacor Pharmaceuticals Inc

2017-03-28 Publication of BRPI0922566A2 publication Critical patent/BRPI0922566A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Urology & Nephrology (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Hematology (AREA)
Immunology (AREA)
Ophthalmology & Optometry (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

BRPI0922566A 2008-12-17 2009-12-17 polimorfo cristalino, composição farmacêutica, composto, e, métodos para preparar um composto, e para tratar uma doença. BRPI0922566A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US13849008P	2008-12-17	2008-12-17
PCT/US2009/068609 WO2010080558A1 (en)	2008-12-17	2009-12-17	Polymorphs of (s)-3-aminomethyl-7-(3-hydroxy-propoxy)-3h-benzo[c][1,2] oxaborol-1-ol

Publications (1)

Publication Number	Publication Date
BRPI0922566A2 true BRPI0922566A2 (pt)	2017-03-28

Family

ID=42316734

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0922566A BRPI0922566A2 (pt)	2008-12-17	2009-12-17	polimorfo cristalino, composição farmacêutica, composto, e, métodos para preparar um composto, e para tratar uma doença.

Country Status (18)

Country	Link
US (1)	US8461364B2 (pt)
EP (1)	EP2378886A4 (pt)
JP (1)	JP2012512262A (pt)
KR (1)	KR20110111407A (pt)
CN (1)	CN102256494A (pt)
AU (1)	AU2009335744A1 (pt)
BR (1)	BRPI0922566A2 (pt)
CA (1)	CA2744231A1 (pt)
CO (1)	CO6390029A2 (pt)
CR (1)	CR20110357A (pt)
DO (1)	DOP2011000183A (pt)
EA (1)	EA201190034A1 (pt)
IL (1)	IL213060A0 (pt)
MA (1)	MA32977B1 (pt)
MX (1)	MX2011006334A (pt)
PE (1)	PE20120052A1 (pt)
SG (1)	SG172040A1 (pt)
WO (1)	WO2010080558A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007078340A2 (en)	2005-12-30	2007-07-12	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
CN103479654B (zh)	2006-02-16	2018-02-09	安纳考尔医药公司	作为抗炎药的含硼的小分子
US8716478B2 (en)	2010-01-27	2014-05-06	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
SMT202000248T1 (it) *	2010-08-10	2020-07-08	Rempex Pharmaceuticals Inc	Derivati di estere di acido boronico ciclico e relativi usi terapeutici
JP5952280B2 (ja)	2010-09-07	2016-07-13	アナコールファーマシューティカルズ，インコーポレーテッド	細菌感染治療用のベンゾオキサボロール誘導体
KR20140114380A (ko)	2011-12-22	2014-09-26	미큐알엑스 파마슈티칼스, 인크.	항미생물 요법용 트리시클릭 붕소 화합물
AU2014212576B2 (en)	2013-01-30	2015-08-13	Agrofresh Inc.	Use of benzoxaboroles as volatile antimicrobial agents on meats, plants, or plant parts
US10070649B2 (en)	2013-01-30	2018-09-11	Agrofresh Inc.	Volatile applications against pathogens
US9585396B2 (en)	2013-01-30	2017-03-07	Agrofresh Inc.	Volatile applications against pathogens
US8669207B1 (en)	2013-01-30	2014-03-11	Dow Agrosciences, Llc.	Compounds and compositions
US11039617B2 (en)	2013-01-30	2021-06-22	Agrofresh Inc.	Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US9598443B2 (en)	2013-02-01	2017-03-21	Anacor Pharmaceuticals, Inc.	Boron containing small molecules as antiprotozoal agents
JP6499175B2 (ja)	2013-08-09	2019-04-10	グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙ（Ｎｏ．２）Ｌｉｍｉｔｅｄ	三環式ベンゾキサボロール化合物及びその使用
WO2016001834A1 (en)	2014-07-01	2016-01-07	Daiichi Sankyo Company, Limited	Tricyclic benzoxaboroles as antibacterial agents
MA41495A (fr)	2015-02-12	2017-12-19	Anacor Pharmaceuticals Inc	Composés benzoxaborole et leurs utilisations
WO2017155879A1 (en)	2016-03-07	2017-09-14	Agrofresh Inc.	Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
MA52337A (fr)	2017-03-01	2021-03-03	Anacor Pharmaceuticals Inc	Nouveaux analogues d'oxaborole et utilisations de ces derniers
WO2022043936A1 (en)	2020-08-31	2022-03-03	Pfizer Inc.	Methods of protecting rna
MX2023007135A (es)	2020-12-17	2023-08-25	Idexx Lab Inc	Detección y tratamiento de la fiebre de las montañas rocosas.

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2260336A (en)	1939-10-16	1941-10-28	Dow Chemical Co	Method of preparation of organic borates
GB1396904A (en)	1972-08-11	1975-06-11	Ici Ltd	Method for the control of micro-organisms
US4766113A (en)	1975-10-24	1988-08-23	Chapman Chemical Company	Antimicrobial compositions and methods of using same
US4602011A (en)	1975-10-24	1986-07-22	Chapman Chemical Company	Antimicrobial compositions and methods of using same
US4716035A (en)	1985-05-24	1987-12-29	The Procter & Gamble Company	Oral compositions and methods for treating gingivitis
US5962498A (en)	1986-06-11	1999-10-05	Procyon Pharmaceuticals, Inc.	Protein kinase C modulators. C. indolactam structural-types with anti-inflammatory activity
US4894220A (en)	1987-01-30	1990-01-16	Colgate-Palmolive Company	Antibacterial antiplaque oral composition
SG47101A1 (en)	1992-07-31	1998-03-20	Us Bioscience	Crystalline amifostine compositions and methods for the preparation and use of same
US5348948A (en)	1993-05-07	1994-09-20	American Cyanamid Company	2,2-diaryl-1-(oxa and thia)-2a-azonia-2-borataacenaphthene fungicidal
US5348947A (en)	1993-05-07	1994-09-20	American Cyanamid Company	Diarylboron ester and thioester fungicidal agents
US5594151A (en)	1994-01-28	1997-01-14	Prolinx, Inc.	Phenylboronic acid complexing reagents derived from aminosalicylic acid
GB9411587D0 (en) *	1994-06-09	1994-08-03	Zeneca Ltd	Compound, composition and use
US6083903A (en)	1994-10-28	2000-07-04	Leukosite, Inc.	Boronic ester and acid compounds, synthesis and uses
GB9604926D0 (en)	1996-03-08	1996-05-08	Sandoz Ltd	Organic compounds
AU3102697A (en)	1996-06-19	1998-01-07	Rhone-Poulenc Rorer Limited	Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
US5831046A (en)	1996-08-05	1998-11-03	Prolinx, Incorporated	Boronic acid-contaning nucleic acid monomers
WO1998012206A1 (en)	1996-09-19	1998-03-26	The Board Of Trustees Of Leland Stanford Jr. University	Dna adenine methyltransferases and uses thereof
DE19829947A1 (de)	1998-07-04	2000-01-05	Bayer Ag	Elektrolumineszierende Anordnungen mit Bor-Chelaten
WO2000044387A1 (fr)	1999-01-29	2000-08-03	Nitto Kasei Co., Ltd.	Composes organobores presentant une activite de coccidiostats
EP1181291A2 (en)	1999-05-25	2002-02-27	The Penn State Research Foundation	Dna methyltransferase inhibitors
US6306628B1 (en)	1999-08-25	2001-10-23	Ambergen, Incorporated	Methods for the detection, analysis and isolation of Nascent proteins
US6369098B1 (en)	1999-10-05	2002-04-09	Bethesda Pharmaceuticals, Inc.	Dithiolane derivatives
CA2415938A1 (en)	2000-07-14	2002-01-24	Zycos Inc.	Alpha-msh related compounds and methods of use
ATE346074T1 (de)	2000-11-30	2006-12-15	Penn State Res Found	Dna methyl transferase inhibitoren
DE10110051C2 (de)	2001-03-02	2003-07-03	Clariant Gmbh	Verfahren zur Herstellung von Boron- und Borinsäuren
GB0117645D0 (en)	2001-07-19	2001-09-12	Isis Innovation	Therapeutic stratergies for prevention and treatment of alzheimers disease
DE10143979A1 (de)	2001-09-07	2003-03-27	Clariant Gmbh	Verfahren zur Herstellung von Bisallylboranen und nicht-aromatischen Boronsäuren
EP1444981A1 (en)	2001-10-11	2004-08-11	Katsuhiko Mikoshiba	Intracellular calcium concentration increase inhibitors
CN1325504C (zh)	2002-01-10	2007-07-11	宾夕法尼亚州研究基金会	制备二芳基硼酸烷基酯和络合的二芳基硼酸的方法
US7390806B2 (en)	2002-12-18	2008-06-24	Anacor Pharmaceuticals, Inc.	Antibiotics containing borinic acid complexes and methods of use
AU2003299821B2 (en)	2002-12-18	2010-02-18	Anacor Pharmaceuticals, Inc.	Antibiotics containing borinic acid complexes and methods of use
WO2005000200A2 (en)	2003-05-09	2005-01-06	Sugen, Inc.	Novel kinases
MXPA05013848A (es)	2003-06-16	2006-09-04	Anacor Pharmaceuticals Inc	Agentes terapeuticos que contienen boro hidroliticamente resistentes y metodos de uso.
KR101300929B1 (ko)	2004-05-12	2013-08-27	더 브리검 앤드 우먼즈 하스피털, 인크.	감염 치료를 위한 겔솔린의 용도
WO2006062731A1 (en)	2004-11-19	2006-06-15	University Of North Texas Health Science Center At Fort Worth	Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye
GB0501944D0 (en)	2005-01-31	2005-03-09	Univ Cambridge Tech	Compounds for use in chemical detection and/or quantitation
MX369262B (es)	2005-02-16	2019-11-04	Anacor Pharmaceuticals Inc	Moleculas pequeñas que contienen boro.
AR054336A1 (es)	2005-03-30	2007-06-20	Astion Dev As	Tratamiento de enfermedades dermatologicas y del prurito
US20080234229A1 (en)	2005-08-18	2008-09-25	Auspex Pharmaceuticals, Inc.	Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders
WO2007078340A2 (en)	2005-12-30	2007-07-12	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
CN103479654B (zh)	2006-02-16	2018-02-09	安纳考尔医药公司	作为抗炎药的含硼的小分子
WO2007146965A2 (en)	2006-06-12	2007-12-21	Anacor Pharmaceuticals, Inc.	Compounds for the treatment of periodontal disease
US20070286822A1 (en)	2006-06-12	2007-12-13	Anacor Pharmaceuticals Inc.	Compounds for the Treatment of Periodontal Disease
JO3396B1 (ar) *	2007-06-20	2019-10-20	Anacor Pharmaceuticals Inc	جزيئات صغيرة تحتوي على البورون
KR100895300B1 (ko)	2007-07-20	2009-05-07	한국전자통신연구원	생체신호 측정의복과 생체신호 처리시스템
WO2009111676A2 (en)	2008-03-06	2009-09-11	Anacor Pharmaceuticals, Inc	Boron-containing small molecules as anti-inflammatory agents
EP2285384A4 (en)	2008-05-12	2012-04-25	Anacor Pharmaceuticals Inc	BORN SMALL MOLECULES
WO2010028005A1 (en)	2008-09-04	2010-03-11	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules
WO2010045505A1 (en)	2008-10-15	2010-04-22	Anacor Pharmaceuticals, Inc	Boron-containing small molecules as anti-protozoal agents
WO2010045503A1 (en)	2008-10-15	2010-04-22	Anacor Pharmaceuticals, Inc.	Boron-containing small molecules as anti-protozoal agents

2009
- 2009-12-17 BR BRPI0922566A patent/BRPI0922566A2/pt not_active IP Right Cessation
- 2009-12-17 EA EA201190034A patent/EA201190034A1/ru unknown
- 2009-12-17 SG SG2011041894A patent/SG172040A1/en unknown
- 2009-12-17 US US12/641,318 patent/US8461364B2/en not_active Expired - Fee Related
- 2009-12-17 MX MX2011006334A patent/MX2011006334A/es not_active Application Discontinuation
- 2009-12-17 WO PCT/US2009/068609 patent/WO2010080558A1/en active Application Filing
- 2009-12-17 MA MA34028A patent/MA32977B1/fr unknown
- 2009-12-17 KR KR1020117016565A patent/KR20110111407A/ko not_active Application Discontinuation
- 2009-12-17 AU AU2009335744A patent/AU2009335744A1/en not_active Abandoned
- 2009-12-17 EP EP09837955A patent/EP2378886A4/en not_active Withdrawn
- 2009-12-17 PE PE2011001246A patent/PE20120052A1/es not_active Application Discontinuation
- 2009-12-17 CA CA2744231A patent/CA2744231A1/en not_active Abandoned
- 2009-12-17 JP JP2011542458A patent/JP2012512262A/ja active Pending
- 2009-12-17 CN CN2009801506662A patent/CN102256494A/zh active Pending
2011
- 2011-05-23 IL IL213060A patent/IL213060A0/en unknown
- 2011-06-09 CO CO11071901A patent/CO6390029A2/es not_active Application Discontinuation
- 2011-06-13 DO DO2011000183A patent/DOP2011000183A/es unknown
- 2011-06-23 CR CR20110357A patent/CR20110357A/es unknown

Also Published As

Publication number	Publication date
PE20120052A1 (es)	2012-02-13
CO6390029A2 (es)	2012-02-29
JP2012512262A (ja)	2012-05-31
WO2010080558A1 (en)	2010-07-15
KR20110111407A (ko)	2011-10-11
CR20110357A (es)	2011-11-11
DOP2011000183A (es)	2011-07-15
US8461364B2 (en)	2013-06-11
AU2009335744A1 (en)	2010-07-15
EA201190034A1 (ru)	2012-02-28
US20110152217A1 (en)	2011-06-23
SG172040A1 (en)	2011-07-28
EP2378886A1 (en)	2011-10-26
CA2744231A1 (en)	2010-07-15
IL213060A0 (en)	2011-07-31
MX2011006334A (es)	2011-09-22
MA32977B1 (fr)	2012-01-02
EP2378886A4 (en)	2012-08-29
CN102256494A (zh)	2011-11-23

Publication	Publication Date	Title
BRPI0922566A2 (pt)	2017-03-28	polimorfo cristalino, composição farmacêutica, composto, e, métodos para preparar um composto, e para tratar uma doença.
BRPI0909691A2 (pt)	2015-08-04	Composto, método para preparar um composto, e, composição farmacêutica
BRPI0905717A2 (pt)	2015-07-14	Composição farmacêutica, processo para preparar uma composição farmacêutica e forma de dosagem farmacêutica
BRPI0914918A2 (pt)	2015-10-20	forma de dosagem farmacêutica, e, método para preparar uma forma de dosagem sólida.
BRPI0908092A2 (pt)	2015-08-25	Edulcorante, método para preparar uma composição edulcorante, e, composição edulcorante
BRPI0916689A2 (pt)	2015-11-17	composição farmacêutica estabilizada, preparação sólida, e, métodos para estabilizar uma composição farmacêutica, e para estabilizar uma preparação sólida.
BRPI1011764A2 (pt)	2016-03-29	composição farmacêutica, e, método para preparar uma composição farmacêutica
BRPI0912384A2 (pt)	2015-10-13	composição, e, método para preparar uma composição
BRPI0910734A2 (pt)	2015-09-29	composto, composição farmacêutica, e, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo.
BRPI0915382A2 (pt)	2017-06-27	composto, composição farmacêutica, e, método para tratar uma doença ou um distúrbio.
BRPI0817423A2 (pt)	2015-06-16	Processos para a preparação de um composto, para a preparação de uma formulação farmacêutica, e para a preparação de um intermediário de um composto, e, composto
BRPI0819218A2 (pt)	2015-05-05	Métodos, estojos e composições para administração de compostos farmacêuticos
BRPI0917196A2 (pt)	2015-11-10	método para a preparação de um complexo, e, forma cristalina de um composto.
BRPI0818533A2 (pt)	2017-06-06	composto, composição farmacêutica, e, processo para a preparação de um composto
BR112012004333A2 (pt)	2015-09-08	composto, composição farmacêutica, e, método para o tratamento ou a prevenção de uma doença ou um distúrbio.
BRPI0912539A2 (pt)	2015-10-13	composto, composição farmacêutica , método para tratar uma doença, e, uso do composto.
BRPI0807756A2 (pt)	2014-06-17	Método para produzir um l-aminoácido.
BRPI1016132A2 (pt)	2016-04-19	composição, formulação farmacêutica, método para fabricar uma formulação farmacêutica estável.
BRPI0909198A2 (pt)	2019-09-24	composto antifolato, composto, método para preparar um composto antifolato, composição farmacêutica, método para tratar
BRPI0613574A2 (pt)	2016-11-16	forma cristalina isolada de um composto, método para preparar um composto, e, composição farmacêutica
BRPI0906475A2 (pt)	2015-07-14	Compostos, processso para a preparação de um composto, composição farmacêutica e uso de um composto
BRPI0910072A2 (pt)	2017-05-30	composto, composição farmaceutic, e, método para prover anestesia a um mamífero.
BRPI0816904A2 (pt)	2015-03-17	Formas sólida, amorfa e cristalina, composição farmacêutica, e, método para tratar uma doença
BRPI1007161A2 (pt)	2016-02-23	composição farmacêutica oral, e processo para preparar uma composição
BR112012003280A2 (pt)	2017-05-23	composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto.

Legal Events

Date	Code	Title	Description
2017-04-04	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2017-07-18	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]